Washington Newborn Hearing Screening Privacy Law Requirements: What Providers and Parents Need to Know

Newborn Hearing Screening Protocols

How screening works

Newborn hearing screening is a quick, noninvasive physiologic test—most often otoacoustic emissions (OAE) and/or automated auditory brainstem response (AABR)—performed before hospital discharge or soon after. The goal is to identify potential hearing differences early so that diagnostic testing and intervention can proceed without delay.

Data elements and documentation

Providers should document the screening date, method used (OAE or AABR), equipment, screener identity, pass/refer result, risk indicators, parent education provided, and referrals made. Only the minimum necessary identifiers (infant name, date of birth, medical record number, and parent contact information) should accompany results.

Reporting to public health

Hospitals and clinics report screening outcomes to the Department of Health’s Early Hearing Detection and Intervention program as a public health activity. While hearing screening is distinct from metabolic blood-spot testing, WAC Chapter 246-650 establishes the broader newborn screening framework that informs standardized reporting, timeliness, and follow-up expectations across programs.

Parental Rights and Consent

Informed choice and access

You have the right to be informed about the purpose, benefits, and limits of newborn hearing screening and to receive results in understandable language. Under Washington’s Uniform Health Information Act (often called the Uniform Health Care Information Act), you may obtain copies of your child’s screening record and request corrections to inaccurate information.

Authorization for sharing and referrals

Care teams may share results with the infant’s primary care provider and necessary specialists for treatment and public health follow-up. Disclosure to early intervention programs beyond public health reporting is typically done with your written authorization so you control information sharing outside required operations.

Parental Consent for Research

Using screening data (or any related materials) for research is not the same as using it for care or public health operations. Parental Consent for Research and appropriate ethics review are required before information is used for research purposes that go beyond mandated screening, quality assurance, or program evaluation.

Specimen Handling and Ownership

No routine biospecimens in hearing screening

Unlike blood-spot newborn screening, routine newborn hearing screening does not create a biological specimen. It generates test measurements and outcome data only. As a result, many specimen-specific rules do not apply to standard hearing screens.

If a specimen is collected during follow-up care

Occasionally, clinical follow-up may involve collecting a specimen (for example, an ear swab to evaluate infection). In those circumstances, the collecting facility or clinical laboratory maintains custody and must safeguard chain of custody and integrity under established procedures.

Public Health Laboratory Specimen Policy

If a specimen is submitted to the state’s public health system for testing, the Public Health Laboratory Specimen Policy governs labeling, transport, receipt, and permitted uses. Parents can ask whether any specimen was collected, where it is held, and for what purpose it may be used.

Specimen Storage and Retention

Routine practice for hearing screening

Because standard hearing screening does not produce a biospecimen, there is typically no specimen to store or retain. What exists are screening results and related notes within the child’s medical record and public health reporting systems.

Records retention

Screening records are retained according to the provider’s medical record retention schedule and applicable state records schedules. The Department of Health may retain de-identified or limited screening data for surveillance and program quality improvement consistent with approved records retention requirements.

Destruction and documentation

When retention periods end, covered entities should securely destroy records or data extracts that are no longer needed, documenting that destruction. Parents may inquire about retention periods and destruction practices used by their child’s providers.

Access Restrictions and Confidentiality

Who may access information

Access is limited to individuals with a legitimate treatment, payment, health care operations, or public health need-to-know, applying the HIPAA minimum-necessary standard. Parents and legal guardians may access their child’s records; other disclosures require authorization unless a specific exception applies.

Workforce safeguards

Personnel with access to hearing screening information should receive privacy training, use unique logins, and sign Confidentiality Agreements. Role-based access controls, audit trails, and secure transmission methods help prevent unauthorized use or disclosure.

Quality improvement protections

Hospitals often analyze aggregate screening performance metrics for quality improvement. In Washington, quality improvement and peer review materials maintained by hospitals are protected from disclosure under RCW 70.41.190, while the patient’s underlying medical record remains accessible to the parent under applicable law.

Compliance with State and Federal Health Information Laws

• HIPAA Privacy and Security Rules: Permit disclosures to public health authorities, require safeguards, and establish individual rights to access and amendments.
• Uniform Health Information Act: Washington’s framework for confidentiality, access, amendment, and authorization standards for health information.
• WAC Chapter 246-650: State newborn screening requirements that, while centered on blood-spot testing, inform cross-program coordination, timeliness, and reporting practices relevant to hearing screening workflows.
• Human subjects protections: Research use of screening information requires Parental Consent for Research and appropriate institutional review, distinct from routine public health operations.
• Contracts and data-sharing: Business associate agreements and data use agreements should define permitted uses, security controls, and breach responsibilities when vendors support screening systems.

HIPAA and Department of Health Responsibilities

Public health uses and disclosures

The Department of Health receives screening results to ensure timely diagnostic follow-up and early intervention, using the data for surveillance, care coordination, and program evaluation. Re-disclosure is limited to what is authorized by law and necessary for these public health purposes.

Hybrid Entity HIPAA structure

The Department of Health operates as a Hybrid Entity HIPAA organization, designating which components perform covered functions. Public health activities related to newborn hearing screening are conducted under public health authority, with safeguards aligned to HIPAA and state confidentiality requirements.

Security, incident response, and accountability

Covered entities and the Department of Health must apply administrative, physical, and technical safeguards, maintain risk assessments, and follow breach notification procedures if protected health information is compromised. Policies should explain parental rights, complaint processes, and how privacy incidents are handled.

Summary

For newborn hearing screening in Washington, privacy protection centers on limited, secure data collection; informed parental participation; and tightly governed public health reporting. Providers should align documentation and reporting with state program expectations, apply HIPAA and the Uniform Health Information Act, and ensure staff uphold confidentiality at every step.

FAQs.

What are the parental rights regarding newborn hearing screening?

You have the right to clear information about the screening, to receive and understand results, to authorize or decline nonrequired disclosures (such as referrals beyond mandated public health follow-up), and to access and request corrections to your child’s record under the Uniform Health Information Act.

How long are newborn hearing screening specimens retained?

Routine hearing screening does not create a biospecimen, so there is ordinarily no specimen retention. Screening results are kept as part of the medical record according to provider and state records schedules, and the Department of Health may retain limited data for public health purposes under its records schedule.

Who can access newborn hearing screening specimens?

Because standard hearing screening does not involve specimens, there is typically nothing to access. If a specimen is collected during clinical follow-up, only authorized clinical or laboratory personnel may access it, and custody follows facility or Public Health Laboratory Specimen Policy requirements.

What laws govern the privacy of newborn hearing screening information?

Key authorities include HIPAA, Washington’s Uniform Health Information Act, hospital quality-improvement confidentiality under RCW 70.41.190, and program requirements informed by WAC Chapter 246-650. Providers also rely on confidentiality policies, training, and signed Confidentiality Agreements to operationalize these rules.